MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

Model Number	142122-05
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Restenosis (4576)
Date of Event	10/14/2022
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of restenosis leading to intervention is listed in the biomimics 3d instructions for use and is a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
Event or Problem Description
The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2021, the patient was implanted with one 5.0 x 80mm biomimics 3d (bm3d) stent in the superficial femoral artery (sfa) distal third to proximal popliteal segment to treat a de novo lesion in the right leg.A contralateral approach was used and the lesion was predilated using percutaneous transluminal angioplasty (pta) balloon and prepared with atherectomy.The target lesion was also post-dilated with pta.The site reported that a right popliteal in-stent restenosis was noted on duplex ultrasound (dus) on (b)(6) 2022.A right leg wound was slow to heal.The patient underwent angiogram and pta/standard balloon angioplasty and laser atherectomy in the right sfa to popliteal artery on (b)(6) 2022.It was reported that the event led to target lesion and target vessel revascularisation.The event outcome was reported as resolved/recovered.The site reported that the event was not related to the study device or study procedure but a worsening of the patient's pre-existing condition.The event was reviewed by veryan and considered possibly related to the device on (b)(6) 2022.It was reported as target lesion related.The device remains implanted.
Event or Problem Description
The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2021, the patient was implanted with one 5.0 x 80mm biomimics 3d (bm3d) stent in the proximal popliteal segment to treat a de novo lesion in the right leg.A contralateral approach was used and the lesion was predilated using percutaneous transluminal angioplasty (pta) balloon and prepared with atherectomy.The target lesion was also post-dilated with pta.The site reported that a right popliteal in-stent restenosis was noted on duplex ultrasound (dus) on (b)(6) 2022.A right leg wound was slow to heal.The patient underwent an angiogram, pta/standard balloon angioplasty and laser atherectomy in the right proximal popliteal (p1) to the distal popliteal (p2) artery on (b)(6) 2022.It was reported as target lesion-related.It was reported that the event led to target lesion/vessel revascularisation (tlr/tvr).The event outcome was reported as resolved/recovered.The site reported that the event was not related to the study device or study procedure but a worsening of the patient's pre-existing condition.The event was reviewed by veryan and considered possibly related to the device on 11-nov-22 the device remains implanted.Additional information received on 27-feb-24 by the site updated the intervention details to reflect that the p1 to p2 segment was that which was intervened on.The target lesion was also updated to reflect the proximal popliteal.
Additional Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of restenosis leading to intervention is listed in the biomimics 3d instructions for use and is a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.Section b.5.Was updated with the target lesion and intervention details.Sections d.3.And g.6.Were updated with the new veryan address which has changed since the initial report, section e.1.Was updated to reflect the physician's email and updated address.Sections g.6.And h.2.Were updated to reflect the type of report and reason and h.11.Reflects the sections of the report that are updated.

• Brand Name: BIOMIMICS 3D VASCULAR STENT SYSTEM
• Common Device Name: BIOMIMICS 3D VASCULAR STENT SYSTEM
• Manufacturer (Section D): VERYAN MEDICAL LTD; block 5; parkmore east business park; galway, H91 V 0TX; EI H91 V0TX
• Manufacturer Contact: alan mcdonagh ; block 5; parkmore east business park; galway, H91 V-0TX ; EI H91 V0TX
• MDR Report Key: 15925105
• Report Number: 3011632150-2022-00104
• Device Sequence Number: 5054166
• Product Code: NIP
• UDI-Device Identifier: 05391526850411
• UDI-Public: (01)05391526850411(17)220424(11)200923(10)0000052817
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: P180003
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2021
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Study,Health Professional
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 03/23/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 04/24/2022
• Device Model Number: 142122-05
• Device Catalogue Number: 142122-05
• Device Lot Number: 0000052817
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/11/2022
• Supplement Date Received by Manufacturer: 02/27/2024
• Initial Report FDA Received Date: 12/06/2022
• Supplement Report FDA Received Date: 03/23/2024
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 09/23/2020
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: ASPIRIN; CLOPIDOGREL (PLAVIX)
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 58 YR
• Patient Sex: Male
• Patient Weight: 232 KG
• Patient Ethnicity: Hispanic